Brooke Michelle E, Spiliopoulos Nicolaos, Collins Margaret
Shoalhaven District Memorial Hospital, Nowra, NSW, Australia.
Rural Remote Health. 2017 Jul-Sep;17(3):4017. doi: 10.22605/RRH4017. Epub 2017 Oct 10.
Chronic obstructive pulmonary disease (COPD) is a chronic, progressive disease, which consumes a significant proportion of the Australian and New Zealand healthcare budget. Studies have shown that people living with COPD outside of urban areas have higher rates of hospitalisations. Two international reviews have demonstrated reduced hospital admissions and length of stay in people with COPD who participate in an integrated disease management program. However, most studies included in these reviews are in urban settings. The purpose of this review is to explore the type and cost-effectiveness of COPD management interventions located in rural or remote settings of Australia and New Zealand in order to inform planning and ongoing service development in the authors' local health district.
Six databases and Google scholar were searched to find literature relating to the availability and cost-effectiveness of non-pharmaceutical interventions for the management of COPD in rural and remote areas of Australia and New Zealand.
Two studies were found that met the inclusion criteria. Both studies had small sample sizes, were single intervention studies and showed a positive influence on variables such as number of hospital admissions and length of stay at 12 months post-intervention. However, because of the limited number of studies and the lack of homogeneity of interventions, no conclusions regarding availability and cost-effectiveness of COPD interventions in rural and remote areas of Australia and New Zealand could be drawn.
Limited literature exists to inform planning and development of services for people with COPD living in rural and remote areas of Australia and New Zealand. Approximately 50% of pulmonary rehabilitation programs are situated in rural and remote locations in Australia and New Zealand. Outcomes from existing programs need to be reported in a consistent and coordinated manner to allow evaluation of health resource utilisation.
慢性阻塞性肺疾病(COPD)是一种慢性进行性疾病,在澳大利亚和新西兰的医疗保健预算中占相当大的比例。研究表明,生活在城市以外地区的慢性阻塞性肺疾病患者住院率更高。两项国际综述显示,参与综合疾病管理项目的慢性阻塞性肺疾病患者的住院次数和住院时间有所减少。然而,这些综述中纳入的大多数研究都是在城市环境中进行的。本综述的目的是探讨澳大利亚和新西兰农村或偏远地区慢性阻塞性肺疾病管理干预措施的类型和成本效益,以便为作者所在当地卫生区的规划和持续服务发展提供信息。
检索了六个数据库和谷歌学术,以查找与澳大利亚和新西兰农村及偏远地区慢性阻塞性肺疾病管理的非药物干预措施的可用性和成本效益相关的文献。
发现两项研究符合纳入标准。两项研究的样本量都很小,都是单一干预研究,并且在干预后12个月对诸如住院次数和住院时间等变量显示出积极影响。然而,由于研究数量有限且干预措施缺乏同质性,无法就澳大利亚和新西兰农村及偏远地区慢性阻塞性肺疾病干预措施的可用性和成本效益得出结论。
现有文献有限,无法为澳大利亚和新西兰农村及偏远地区慢性阻塞性肺疾病患者的服务规划和发展提供信息。在澳大利亚和新西兰,约50%的肺康复项目位于农村和偏远地区。现有项目的结果需要以一致和协调的方式报告,以便评估卫生资源的利用情况。